Biocon Limited BIOCON.NS Open Biocon Limited in new tab
Biocon Limited Analysis (BIOCON.NS)
Is Biocon Limited a good investment? Biocon Limited (BIOCON.NS) is currently trading at 429.85 INR. Market analysts have a consensus price target of 421.05 INR. This suggests the asset is currently trading above analyst expectations.
In terms of valuation, the stock trades at a P/E ratio of 151.44. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Biocon Limited is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is 12.02.
For income investors, Biocon Limited pays a dividend yield of 0.14%. With a payout ratio of 11%, the dividend appears sustainable.
Investor FAQ
Does Biocon Limited pay a dividend?
Yes, it pays an annual dividend of 0.50 INR (0.14% yield).
What asset class is Biocon Limited?
Biocon Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of 2.84.
Company Profile
Biocon Limited, together with its subsidiaries, manufactures and sells biotechnology products and research services in India, the United States, Ireland, rest of the European Union, and internationally. It operates through Generics, Biosimilars, and Research segments. The company offers generic formulations and API products, including cardiovascular, anti-diabetics, obesity, multiple sclerosis, anti-fungal, anti-cancer, immunosuppressants, and specialty molecules; and biosimilars products consisting of pegfilgrastim, trastuzumab, bevacizumab, adalimumab, etanercept, ustekinumab, glargine, aspart, insulins, and aflibercept. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer goods, and agrochemical companies. In addition, the company offers enzyme, biopharmaceutical, and medicinal goods; contract research and manufacturing services, and other research and development in the fields of pharmaceuticals, drug discovery, biotechnology pharmaceuticals, and medicinal sciences, etc.; clinical research; and business support and development, and marketing services. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.
Dividend Yield
0.14% (5y avg: 1.16%)
Annual Dividends
0.50 INR
Next ex. div date
July 4, 2025
Payout Ratio
11.07%
Historical Dividends
| Year | Total Dividends |
|---|---|
| 2026 | 0.50 INR |
| Aug. 3, 2026 (estimated) | 0.5000 |
| 2025 | 0.50 INR |
| Aug. 22, 2025 | 0.5000 |
| 2024 | 0.50 INR |
| Aug. 23, 2024 | 0.5000 |
| 2023 | 1.50 INR |
| Sept. 8, 2023 | 1.5000 |
| 2022 | 0.50 INR |
| Aug. 28, 2022 | 0.5000 |
| 2019 | 0.50 INR |
| Aug. 2, 2019 | 0.5000 |
| 2018 | 0.50 INR |
| Aug. 26, 2018 | 0.5000 |
| 2017 | 0.50 INR |
| Aug. 4, 2017 | 0.5000 |
| 2016 | 0.83 INR |
| July 1, 2016 | 0.8333 |
| 2015 | 0.83 INR |
| April 15, 2015 | 0.8333 |
| 2014 | 0.83 INR |
| July 31, 2014 | 0.8333 |
| 2013 | 1.25 INR |
| July 31, 2013 | 1.2500 |
| 2012 | 0.83 INR |
| July 31, 2012 | 0.8333 |
| 2011 | 0.75 INR |
| July 27, 2011 | 0.5000 |
| May 12, 2011 | 0.2500 |
| 2010 | 0.58 INR |
| Aug. 22, 2010 | 0.5833 |
| 2009 | 0.50 INR |
| Aug. 1, 2009 | 0.5000 |
| 2008 | 0.42 INR |
| Aug. 1, 2008 | 0.4167 |
| 2007 | 0.25 INR |
| Aug. 1, 2007 | 0.2500 |
| 2006 | 0.21 INR |
| July 16, 2006 | 0.2083 |
| 2005 | 0.17 INR |
| July 16, 2005 | 0.1667 |
| 2004 | 0.08 INR |
| July 1, 2004 | 0.0833 |
Yearly aggregated dividends
Dividends
|
Biocon Limited
Aug 22, 2025 Paid
Dividend
0.5 INR |
Historical Split Corporate Actions
| Split Date | Split Ratio to 1 |
|---|---|
| June 12, 2019 | 2.000000 |
| June 15, 2017 | 3.000000 |
| Sept. 11, 2008 | 2.000000 |
Explore Premium Features
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion